The DOI matches its Crossref record; 523 of the 523 references it cites were found in a registry or an index.
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Open accessAbstract
Genetic mutations and abnormal gene regulation are key mechanisms underlying tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores, represent the basic units of chromatin. The fifth amino group (Nε) of histone lysine residues is a common site for post-translational modifications (PTMs), and of these, acetylation is the second most common. Histone acetylation is modulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), and is involved in the regulation of gene expression. Over the past two decades, numerous studies characterizing HDACs and HDAC inhibitors (HDACi) have provided novel and exciting insights concerning their underlying biological mechanisms and potential anti-cancer treatments. In this review, we detail the diverse structures of HDACs and their underlying biological functions, including transcriptional regulation, metabolism, angiogenesis, DNA damage response, cell cycle, apoptosis, protein degradation, immunity and other several physiological processes. We also highlight potential avenues to use HDACi as novel, precision cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–523 of 523
HDAC5 controls the functions of Foxp3+ T‐regulatory and CD8+ T cells
Xiao, H., Jiao, J., Wang, L., O’Brien, S., Newick, K., Wang, L. S., Falkensammer, E., Liu, Y., Han, R., Kapoor, V., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29979 · Cited by 77
Fiskus, W. C., Coothankandaswamy, V., Chen, J., Ma, H., Ha, K., Saenz, D. T., Krieger, S., Mill, C. P., Sun, B., Huang, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0126 · Cited by 77
Kim, D. J., Dunleavey, J. M., Xiao, L., Ollila, D. W., Troester, M. A., Otey, C. A., Li, W., Barker, T. H., & Dudley, A. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0072-3 · Cited by 77
Li, Y., Peng, L., & Seto, E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00400-15 · Cited by 76
Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors
Yang, L., Ma, X., He, Y., Chen, Y., Chen, Q., Li, G., & Chen, X. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0060-7 · Cited by 76
Self-citationSIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription
Blank, M. F., Chen, S., Poetz, F., Schnölzer, M., Voit, R., & Grummt, I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx053 · Cited by 76
Ho, M., Chen, T., Liu, J., Dowling, P., Hideshima, T., Zhang, L., Morelli, E., Camci‐Unal, G., Wu, X., Tai, Y., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0493-x · Cited by 76
Woods, D. M., Woan, K. V., Cheng, F., Sodré, A. L., Wang, D., Wu, Y., Wang, Z., Chen, J., Powers, J., Pinilla-Ibarz, J., et al. (2017) · Blood · doi:10.1182/blood-2016-08-731505 · Cited by 74 · cited 1×
“…Nucleus (nucleoplasm) Enhances type I IFN signaling Cao et al., 2019 Enhances proinflammatory cytokine production, proliferation of T cells and GVHD Woods et al., 2017 Confers a metabolic homeostasis disorder Bagchi et al., 2018; Sun et al., 2018 Suppresses JAK2-driven proliferation and…”
BackgroundMelatonin and the von Hippel–Lindau/HIF-1 oxygen sensing mechanism: A review
Vriend, J. P., & Reiter, R. J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.004 · Cited by 74
Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth
Nakazawa, M. S., Eisinger‐Mathason, T. S. K., Sadri, N., Ochocki, J. D., Gade, T. P. F., Amin, R. K., & Simon, M. C. (2016) · Nature Communications · doi:10.1038/ncomms10539 · Cited by 74
Lu, Y., Stuart, J. H., Talbot-Cooper, C., Singh, S. A., Huntly, B. J. P., Smid, A. I., Snowden, J. S., Dupont, L., & Smith, G. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816399116 · Cited by 73
Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation
Yang, Y., Tse, A. K.-W., Li, P., Ma, Q., Xiang, S., Nicosia, S. V., Seto, E., Zhang, X., & Bai, W. (2011) · Oncogene · doi:10.1038/onc.2010.600 · Cited by 72
Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., Zhang, J., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211796 · Cited by 72
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Winter, M., Moser, M., Meunier, D., Fischer, C., Machat, G., Mattes, K., Lichtenberger, B. M., Brunmeir, R., Weissmann, S., Murko, C., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.243 · Cited by 72
Newkirk, T. L., Bowers, A. A., & Williams, R. M. (2009) · Natural Product Reports · doi:10.1039/b817886k · Cited by 72
Huang, Z., Zhou, W., Li, Y., Cao, M., Wang, T., Ma, Y., Guo, Q., Wang, X., Zhang, C., Zhang, C., et al. (2018) · Theranostics · doi:10.7150/thno.26627 · Cited by 72
Jiang, Y., & Hsieh, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411939111 · Cited by 71
Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M., Babb, J. S., Barnett, E. S., Gómez-Pinillos, A., Liu, X., Moore, D. F., DiPaola, R. S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1589 · Cited by 71
The sirtuin SIRT6 regulates stress granules formation in C. elegans and in mammals
Jedrusik, M. A., Studencka‐Turski, M., Smolka, C., Baumann, T., Schmidt, H., Kampf, J., Paap, F., Martin, S., Tazi, J., Müller, K. M., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.130708 · Cited by 69
Ban, J., Aryee, D. N. T., Fourtouna, A., van der Ent, W., Kauer, M., Niedan, S., Machado, I., Galindo, C. R., Tirado, Ò. M., Schwentner, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1736 · Cited by 69
Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents
Zhang, P.-Y., Li, G., Deng, Z., Liu, L., Chen, L., Tang, J., Wang, Y.-Q., Cao, S.-T., Fang, Y., Wen, F., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1504 · Cited by 69
Self-citationXu, L., Li, Y., Zhou, L., Dorfman, R. G., Liu, L., Cai, R., Jiang, C., Tang, D., Wang, Y., Zou, X., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2089 · Cited by 69
Tong, J., Zheng, X., Tan, X., Fletcher, R., Nikolovska‐Coleska, Z., Yu, J., & Zhang, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0399 · Cited by 68
Tang, S., Huang, G., Fan, W., Chen, Y., Ward, J. M., Xu, X., Xu, Q., Kang, A., McBurney, M. W., Fargo, D. C., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.07.011 · Cited by 67
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Yue, L., Sharma, V., Horvat, N. P., Akuffo, A. A., Beatty, M. S., Murdun, C., Colin, C., Billington, J. M. R., Goodheart, W. E., Sahakian, E., et al. (2020) · Blood · doi:10.1182/blood.2019895326 · Cited by 67
Santos‐Barriopedro, I., Bosch‐Presegué, L., Marazuela-Duque, A., de la Torre, C., Colomer, C., Vázquez, B. N., Fuhrmann, T., Martínez-Pastor, B., Lu, W., Braun, T. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02586-x · Cited by 66
Martin, M. W., Lee, J. Y., Lancia, D. R., Ng, P. Y., Han, B., Thomason, J. R., Lynes, M. S., Marshall, C. G., Conti, C., Collis, A. J., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.021 · Cited by 66
Chen, G., Zhang, B., Xu, H., Sun, Y., Shi, Y., Luo, Y., Jia, H., & Wang, F. (2017) · Oncogene · doi:10.1038/onc.2017.297 · Cited by 65
De, U., Son, J. Y., Sachan, R., Park, Y. J., Kang, D., Yoon, K., Lee, B. M., Kim, I. S., Moon, H. R., & Kim, H. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092743 · Cited by 63
Newbold, A., Salmon, J. M., Martin, B. P., Stanley, K., & Johnstone, R. W. (2013) · Oncogene · doi:10.1038/onc.2013.482 · Cited by 62
Phelps, M. P., Bailey, J. N., Vleeshouwer-Neumann, T., & Chen, E. Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610270114 · Cited by 62
The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage
Wang, H., Zhou, W., Zheng, Z., Zhang, P., Tu, B., He, Q., & Zhu, W. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.014 · Cited by 61
Self-citationRadhakrishnan, R., Li, Y., Xiang, S., Yuan, F., Yuan, Z., Telles, E., Fang, J., Coppola, D., Shibata, D., Lane, W. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612945 · Cited by 60
Identification of a novel SIRT7 inhibitor as anticancer drug candidate
Kim, J. H., Kim, D., Cho, S. J., Jung, K.-Y., Kim, J., Lee, J. M., Jung, H. J., & Kim, K. R. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.120 · Cited by 60
Itoh, T., Fairall, L., Muskett, F. W., Milano, C. P., Watson, P. J., Arnaudo, N., Saleh, A., Millard, C. J., El‐Mezgueldi, M., Martino, F., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv068 · Cited by 59
Azagra, A., Román-González, L., Collazo, O., Rodríguez‐Ubreva, J., de Yébenes, V. G., Barneda‐Zahonero, B., Rodríguez, J., de Moura, M. C., Grego‐Bessa, J., Fernández-Duran, I., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150821 · Cited by 59
McKinsey, T. A., Kuwahara, K., Bezprozvannaya, S., & Olson, E. N. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0612 · Cited by 58
O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression
Zhu, G., Tao, T., Zhang, D., Liu, X., Qiu, H., Han, L., Xu, Z., Xiao, Y., Cheng, C., & Shen, A. (2016) · Glycobiology · doi:10.1093/glycob/cww025 · Cited by 58
Hua, W.-K., Qi, J., Cai, Q., Carnahan, E., Ayala Ramirez, M., Li, L., Marcucci, G., & Kuo, Y.-H. (2017) · Blood · doi:10.1182/blood-2017-03-771386 · Cited by 57
Li, H., Tian, Z., Qu, Y., Yang, Q., Guan, H., Shi, B., Ji, M., & Hou, P. (2018) · Oncogene · doi:10.1038/s41388-018-0434-6 · Cited by 57
Giorgio, E. D., Dalla, E., Franforte, E., Paluvai, H., Minisini, M., Trevisanut, M., Picco, R., & Brancolini, C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1120 · Cited by 57
Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitors
Lee, J., Choy, M. L., Ngo, L., Venta-Perez, G., & Marks, P. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117544108 · Cited by 55
SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells
Sun, Q., Ding, L., Johnson, K. J., Zhou, S., Tyner, J. W., Yang, H. H., Doan, N., SAID, J. W., Xiao, J., Loh, X.-Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0865-8 · Cited by 55
Histone Deacetylase 3 Is Required for T Cell Maturation
Hsu, F., Belmonte, P. J., Constans, M., Chen, M. W., McWilliams, D. C., Hiebert, S. W., & Shapiro, V. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500435 · Cited by 54
Sequence-Specific Recognition of a PxLPxI/L Motif by an Ankyrin Repeat Tumbler Lock
Xu, C., Jin, J., Bian, C., Lam, R., Tian, R., Weist, R., You, L., Nie, J., Bochkarev, A. V., Tempel, W., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002979 · Cited by 54
Cosenza, M., Civallero, M., Marcheselli, L., Sacchi, S., & Pozzi, S. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1364-4 · Cited by 54
Lee, E., Furukubo, T., Miyabe, T., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01033-2 · Cited by 53
Bradley, E. W., Shull, L. C., Olson, E. N., & Westendorf, J. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596247 · Cited by 53
Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
Adams, C. M., Hiebert, S. W., & Eischen, C. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1751 · Cited by 53
Yan, Y., An, J., Yang, Y., Wu, D., Bai, Y., Cao, W., Ma, L., Chen, J., Yu, Z., He, Y., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708478 · Cited by 53
PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy
Nishimori, S., Lai, F., Shiraishi, M., Kobayashi, T., Kozhemyakina, E. A., Yao, T., Lassar, A. B., & Kronenberg, H. M. (2019) · JCI Insight · doi:10.1172/jci.insight.97903 · Cited by 53
RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Carafa, V., Nebbioso, A., Cuomo, F., Rotili, D., Cobellis, G., Bontempo, P., Baldi, A., Spugnini, E. P., Citro, G., Chambery, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3081 · Cited by 52
HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
Lin, C., Tsai, M.-L., Lin, C., Hsu, K., Hsieh, W.-S., Chi, W.-M., Huang, L., & Lee, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020454 · Cited by 52
Histone modifications in DNA damage response
Cao, L., Shen, C., & Zhu, W. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5011-z · Cited by 51
Self-citationSIRT2‐mediated inactivation of p73 is required for glioblastoma tumorigenicity
Funato, K., Hayashi, T., Echizen, K., Negishi, L., Shimizu, N., Koyama‐Nasu, R., Nasu‐Nishimura, Y., Morishita, Y., Tabar, V. S., Todo, T., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745587 · Cited by 51
Kaliszczak, M. A., van Hechanova, E., Li, Y., Al-Sadah, H. A., Parzych, K., Auner, H. W., & Aboagye, E. O. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0232-5 · Cited by 51
Metabolism, cytoskeleton and cellular signalling in the grip of protein Nϵ ‐ and O‐acetylation
Yang, X., & Grégoire, S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400977 · Cited by 50
Sen, N., Kumari, R., Singh, M. I., & Das, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.003 · Cited by 50
Nuclear export modulates the cytoplasmic Sir2 homologue Hst2
Wilson, J. M., Le, V. Q., Zimmerman, C. T., Marmorstein, R., & Pillus, L. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400829 · Cited by 50
HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression
Hu, T., Schreiter, F. C., Bagchi, R. A., Tatman, P. D., Hannink, M., & McKinsey, T. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007006 · Cited by 50
Tae, I. H., Son, J. Y., Lee, S. H., Ahn, M.-Y., Yoon, K., Yoon, S., Moon, H. R., & Kim, H. S. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.44343 · Cited by 50
Zullo, K. M., Guo, Y., Cooke, L. S., Jirau-Serrano, X., Mangone, M. A., Scotto, L., Amengual, J. E., Mao, Y., Nandakumar, R., Cremers, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0033 · Cited by 49
Ustinova, K., Nováková, Z., Saito, M., Meleshin, M., Mikesova, J., Kutil, Z., Baranová, P., Havlínová, B., Schutkowski, M., Matthias, P., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011243 · Cited by 49
CBP-mediated Slug acetylation stabilizes Slug and promotes EMT and migration of breast cancer cells
Dai, X., Xin, Y., Xu, W., Tian, X., Wei, X., & Zhang, H. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1736-5 · Cited by 49
Nicholson, J., Jevons, S. J., Grošelj, B., Ellermann, S. F., Konietzny, R., Kerr, M., Kessler, B. M., & Kiltie, A. E. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3232 · Cited by 48
HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma
Li, Y., Zhang, X., Zhu, S., Dejene, E. A., Peng, W., Sepulveda, A. R., & Seto, E. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3613 · Cited by 48
Nguyen, P., Lee, S., Lorang-Leins, D., Trepel, J. B., & Smart, D. D. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0223-t · Cited by 47
Hershberger, K. A., Abraham, D., Liu, J., Locasale, J. W., Grimsrud, P. A., & Hirschey, M. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002187 · Cited by 47
Enhancer RNAs: a missing regulatory layer in gene transcription
Mao, R., Wu, Y., Ming, Y., Xu, Y., Wang, S., Chen, X., Wang, X., & Fan, Y. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9370-9 · Cited by 46
Sub-cellular localization, expression and functions of Sirt6 during the cell cycle in HeLa cells
Ardestani, P. M., & Liang, F. (2012) · Nucleus · doi:10.4161/nucl.21134 · Cited by 45
Shi, K., Yin, X., Cai, M., Yan, Y., Jia, C., Ma, P., Zhang, S., Zhang, Z., Gu, Z., Zhang, M., et al. (2019) · eLife · doi:10.7554/elife.44306 · Cited by 44
van Tilburg, C. M., Milde, T., Witt, R., Ecker, J., Hielscher, T., Seitz, A., Schenk, J.-P., Buhl, J. L., Riehl, D., Frühwald, M. C., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0775-1 · Cited by 44
Popat, R., Brown, S., Flanagan, L. M., Hall, A., Gregory, W. M., Kishore, B., Streetly, M. J., Oakervee, H. E., Yong, K., Cook, G., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30165-x · Cited by 43
Rezazadeh, S., Yang, D. X., Biashad, S. A., Firsanov, D., Takasugi, M., Gilbert, M. B., Tombline, G., Bhanu, N. V., Garcia, B. A., Seluanov, A., et al. (2020) · Aging · doi:10.18632/aging.103567 · Cited by 43
Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc
Sun, Y., Liu, P. Y., Scarlett, C. J., Malyukova, A., Liu, B., Marshall, G. M., MacKenzie, K. L., Biankin, A. V., & Liu, T. (2013) · Oncogene · doi:10.1038/onc.2013.253 · Cited by 42
Shaw, E., Talwadekar, M., Rashida, Z., Mohan, N., Acharya, A., Khatri, S., Laxman, S., & Kolthur‐Seetharam, U. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00212-19 · Cited by 42
Cadot, B., Brunetti, M., Coppari, S., Fedeli, S., de Rinaldis, E., Russo, C. D., Gallinari, P., Francesco, R. D., Steinkühler, C., & Filocamo, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2796 · Cited by 41
Shinsky, S. A., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00079 · Cited by 41
SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
Lu, Y.-F., Xu, X.-P., Lu, X.-P., Zhu, Q., Liu, G., Bao, Y.-T., Wen, H., Li, Y.-L., Gu, W., & Zhu, W.-G. (2020) · Oncogene · doi:10.1038/s41388-020-1305-5 · Cited by 40
Self-citationYun, T., Yu, K., Yang, S., Cui, Y., Wang, Z., Ren, H., Chen, S., Li, L., Liu, X., Fang, M., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706341 · Cited by 40
Kościuczuk, E. M., Mehrotra, S., Saleiro, D., Kroczyńska, B., Majchrzak-Kita, B., Lisowski, P., Driehaus, C., Rogalska, A., Turner, A. E., Lienhoop, T., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005956 · Cited by 40
Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
Kutil, Z., Mikešová, J., Zessin, M., Meleshin, M., Nováková, Z., Alquicer, G., Kozikowski, A. P., Sippl, W., Bařinka, C., & Schutkowski, M. (2019) · ACS Omega · doi:10.1021/acsomega.9b02808 · Cited by 40
Castañeda, C. A., Wolfson, N. A., Leng, K. W., Kuo, Y., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 39
p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis
Li, M., Hou, T., Gao, T., Lu, X., Yang, Q., Zhu, Q., Li, Z., Liu, C., Mu, G., Liu, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0984-0 · Cited by 39
Self-citationTian, Y., Wei, L., Shi, J., Jiang, K., Xu, H., Hu, L., Kong, L., Zhang, Y., Meng, S., & Piao, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-5852-5 · Cited by 39
Self-citationGLP-catalyzed H4K16me1 promotes 53BP1 recruitment to permit DNA damage repair and cell survival
Lu, X., Tang, M., Zhu, Q., Yang, Q., Li, Z., Bao, Y., Liu, G., Hou, T., Lv, Y., Zhao, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz897 · Cited by 39
Self-citationQi, H., Shi, X., Yu, M., Liu, B., Liu, M., Shi, S., Chen, S., Zou, J., Zhu, W., & Luo, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003629 · Cited by 38
Self-citationWang, J., Jiang, J., Chen, H., Wang, L., Guo, H., Yang, L., Xiao, D., Qing, G., & Liu, H. (2019) · Oncogene · doi:10.1038/s41388-019-0912-5 · Cited by 38
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Preglej, T., Hamminger, P., Luu, M., Bulat, T., Andersen, L., Göschl, L., Stolz, V., Rica, R., Sandner, L., Waltenberger, D., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133393 · Cited by 36
Sirt1 carboxyl-domain is an ATP-repressible domain that is transferrable to other proteins
Kang, H., Oka, S., Lee, D., Park, J. H., Aponte, A. M., Jung, Y., Bitterman, J. L., Zhai, P., He, Y., Kooshapur, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15560 · Cited by 36
Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
Betsch, A., Rutgeerts, O., Fevery, S., Sprangers, B., Verhoef, G. E. G., Dierickx, D., & Beckers, M. (2018) · Blood Reviews · doi:10.1016/j.blre.2018.04.006 · Cited by 36
Medon, M., Vidacs, E., Vervoort, S. J., Li, J., Jenkins, M. R., Ramsbottom, K. M., Trapani, J. A., Smyth, M. J., Darcy, P. K., Atadja, P. W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2247 · Cited by 35
Toubai, T., Tamaki, H., Peltier, D., Rossi, C., Oravecz-Wilson, K. I., Liu, C., Zajac, C. K., Wu, J. J., Sun, Y., Fujiwara, H., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800148 · Cited by 35
Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins
Ali, I., Ruiz, D. G., Ni, Z., Johnson, J. R., Zhang, H., Li, P.-C., Khalid, M. M., Conrad, R. J., Guo, X., Min, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.008 · Cited by 35
Ning, Y., Ding, J., Sun, X. Y., Xie, Y., Su, M., Ma, C., Pan, J., Chen, J., Jiang, H., & Qi, C. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000529 · Cited by 35
Sirt1 protects from K‐Ras‐driven lung carcinogenesis
Costa‐Machado, L. F., Martín‐Hernández, R., Sánchez‐Luengo, M. Á., Hess, K., Vales‐Villamarín, C., Barradas, M., Lynch, C. J., de la Nava, D., Díaz‐Ruiz, A., de Cabo, R., et al. (2018) · EMBO Reports · doi:10.15252/embr.201643879 · Cited by 34
Kutateladze, T. G. (2011) · Cell · doi:10.1016/j.cell.2011.08.022 · Cited by 31
Adams, C. M., & Eischen, C. M. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.9 · Cited by 31
Lim, B., Murthy, R. K., Lee, J., Jackson, S. A., Iwase, T., Davis, D. W., Willey, J. S., Wu, J., Shen, Y., Tripathy, D., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0473-y · Cited by 30
Natural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers
Lascano, S., Lopez, M., & Arimondo, P. B. (2018) · The Chemical Record · doi:10.1002/tcr.201800133 · Cited by 27
O-GlcNAcylation Regulates Primary Ciliary Length by Promoting Microtubule Disassembly
Tian, J. L., & Qin, H. (2019) · iScience · doi:10.1016/j.isci.2019.01.031 · Cited by 27
Guo, H., Zeng, D., Zhang, H., Bell, T., Yao, J., Liu, Y., Huang, S., Li, C. J., Lorence, E., Zhou, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0550-3 · Cited by 26
Novel protein–protein interactions of TPPII, p53, and SIRT7
Nahálková, J. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2507-y · Cited by 24
Sirtuins: Nodes Connecting Aging, Metabolism and Tumorigenesis
Yao, Y., Yang, Y., & Zhu, W. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990513 · Cited by 24
Self-citationObayashi, H., Nagano, Y., Takahashi, T., Seki, T., Tanaka, S., Sakai, N., Matsumoto, M., & Maruyama, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.12.048 · Cited by 23
Tenovin-6 impairs autophagy by inhibiting autophagic flux
Yuan, H., Tan, B., & Gao, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.25 · Cited by 22
Post-translational modifications of nuclear sirtuins
Zhao, K., & Zhou, Z. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00001-x · Cited by 21
Autophagy and DNA damage repair
Guo, C., & Zhao, Y. (2020) · Genome Instability & Disease · doi:10.1007/s42764-020-00016-9 · Cited by 21
SIRT7 Deacetylates STRAP to Regulate p53 Activity and Stability
Yu, M., Shi, X., Ren, M., Liu, L., Qi, H., Zhang, C., Zou, J., Qiu, X., Zhu, W., Zhang, Y. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114122 · Cited by 20
Self-citationCencioni, C., Spallotta, F., Savoia, M., Kuenne, C. T., Günther, S., Re, A., Wingert, S., Rehage, M., Sürün, D., Siragusa, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03668-0 · Cited by 19
HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML
Huang, F., Sun, J., Chen, W., He, X., Zhu, Y., Dong, H., Wang, H., Li, Z., Zhang, L., Khaled, S. K., et al. (2020) · Aging · doi:10.18632/aging.103605 · Cited by 19
HDAC 2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing
Park, I., Kwon, M., Paik, S., Kim, H.-J., Lee, H., Choi, E., & Lee, H. (2017) · FEBS Journal · doi:10.1111/febs.14286 · Cited by 17
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer
Carafa, V., Poziello, A., Torre, L. D., Giovannelli, P., Donato, M. D., Safadeh, E., Yu, Z., Baldi, A., Castoria, G., Tomaselli, D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225654 · Cited by 17
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies
Norsworthy, K. J., Cho, E., Arora, J. K., Kowalski, J., Tsai, H., Warlick, E. D., Showel, M. M., Pratz, K. W., Sutherland, L., Gore, S. D., et al. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.09.003 · Cited by 14
Igase, M., FUJIKI, N., Shibutani, S., Sakai, H., Noguchi, S., Nemoto, Y., & Mizuno, T. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111810 · Cited by 14
Agarwal, N., McPherson, J. P., Bailey, H., Gupta, S. V., Werner, T. L., Reddy, G., Bhat, G., Bailey, E. B., & Sharma, S. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2934-1 · Cited by 13
Sirt2 Regulates Radiation-Induced Injury
Nguyen, P., Shukla, S., Liu, R., Abbineni, G., & Smart, D. D. (2019) · Radiation Research · doi:10.1667/rr15282.1 · Cited by 13
UNG2 deacetylation confers cancer cell resistance to hydrogen peroxide-induced cytotoxicity
Bao, Y., Tong, L., Song, B., Liu, G., Zhu, Q., Lu, X., Zhang, J., Lu, Y.-F., He, W., Tian, Y., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.010 · Cited by 12
Self-citationPuvvada, S. D., Guillen-Rodriguez, J., Rivera, X. I., Heard, K., Inclán, L., Schmelz, M., Schatz, J. H., & Persky, D. O. (2017) · Oncology · doi:10.1159/000479230 · Cited by 10
Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma development and growth in vivo
Moon, H., Zhu, J., & White, A. C. (2018) · Experimental Dermatology · doi:10.1111/exd.13845 · Cited by 10
Zhu, W. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-0353-0 · Cited by 9
Self-citationRegulation of DNA damage-induced ATM activation by histone modifications
Li, Z., Chen, Y., Tang, M., Li, Y., & Zhu, W. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00004-8 · Cited by 9
Self-citationDeacetylation of a deacetylase drives the DNA damage response
Ng, R., & Huen, M. S. Y. (2020) · Genome Instability & Disease · doi:10.1007/s42764-020-00018-7 · Cited by 2
Cited by
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Mustafa, M., Ahmad, R., Tantry, I. Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Moinuddin, Hassan, M. I., Habib, S., et al. (2024) · Cells · doi:10.3390/cells13221838 · Cited by 595
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
The role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 297
Metadata
- Authors
- Li, G., Tian, Y., & Zhu, W.-G.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-29
- Volume
- 8
- Pages
- 576946-576946
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3090676142
- Cited by
- 352
- References
- 523
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.